These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 37030292)

  • 1. Discovery of phage determinants that confer sensitivity to bacterial immune systems.
    Stokar-Avihail A; Fedorenko T; Hör J; Garb J; Leavitt A; Millman A; Shulman G; Wojtania N; Melamed S; Amitai G; Sorek R
    Cell; 2023 Apr; 186(9):1863-1876.e16. PubMed ID: 37030292
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bacterial Retrons Function In Anti-Phage Defense.
    Millman A; Bernheim A; Stokar-Avihail A; Fedorenko T; Voichek M; Leavitt A; Oppenheimer-Shaanan Y; Sorek R
    Cell; 2020 Dec; 183(6):1551-1561.e12. PubMed ID: 33157039
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Abortive Infection: Bacterial Suicide as an Antiviral Immune Strategy.
    Lopatina A; Tal N; Sorek R
    Annu Rev Virol; 2020 Sep; 7(1):371-384. PubMed ID: 32559405
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microbial Arsenal of Antiviral Defenses. Part II.
    Isaev AB; Musharova OS; Severinov KV
    Biochemistry (Mosc); 2021 Apr; 86(4):449-470. PubMed ID: 33941066
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-CRISPRs go viral: The infection biology of CRISPR-Cas inhibitors.
    Li Y; Bondy-Denomy J
    Cell Host Microbe; 2021 May; 29(5):704-714. PubMed ID: 33444542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phage single-stranded DNA-binding protein or host DNA damage triggers the activation of the AbpAB phage defense system.
    Sasaki T; Takita S; Fujishiro T; Shintani Y; Nojiri S; Yasui R; Yonesaki T; Otsuka Y
    mSphere; 2023 Dec; 8(6):e0037223. PubMed ID: 37882551
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Covalent Modifications of the Bacteriophage Genome Confer a Degree of Resistance to Bacterial CRISPR Systems.
    Liu Y; Dai L; Dong J; Chen C; Zhu J; Rao VB; Tao P
    J Virol; 2020 Nov; 94(23):. PubMed ID: 32938767
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coevolution between bacterial CRISPR-Cas systems and their bacteriophages.
    Watson BNJ; Steens JA; Staals RHJ; Westra ER; van Houte S
    Cell Host Microbe; 2021 May; 29(5):715-725. PubMed ID: 33984274
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RNA-based regulation in bacteria-phage interactions.
    Saunier M; Fortier LC; Soutourina O
    Anaerobe; 2024 Jun; 87():102851. PubMed ID: 38583547
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microbial Arsenal of Antiviral Defenses - Part I.
    Isaev AB; Musharova OS; Severinov KV
    Biochemistry (Mosc); 2021 Mar; 86(3):319-337. PubMed ID: 33838632
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phage-Encoded Anti-CRISPR Defenses.
    Stanley SY; Maxwell KL
    Annu Rev Genet; 2018 Nov; 52():445-464. PubMed ID: 30208287
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Type I-F CRISPR-Cas resistance against virulent phages results in abortive infection and provides population-level immunity.
    Watson BNJ; Vercoe RB; Salmond GPC; Westra ER; Staals RHJ; Fineran PC
    Nat Commun; 2019 Dec; 10(1):5526. PubMed ID: 31797922
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phage Against the Machine: Discovery and Mechanism of Type V Anti-CRISPRs.
    Marino ND
    J Mol Biol; 2023 Apr; 435(7):168054. PubMed ID: 36934807
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The bacterial defense system MADS interacts with CRISPR-Cas to limit phage infection and escape.
    Maestri A; Pons BJ; Pursey E; Chong CE; Gandon S; Custodio R; Olina A; Agapov A; Chisnall MAW; Grasso A; Paterson S; Szczelkun MD; Baker KS; van Houte S; Chevallereau A; Westra ER
    Cell Host Microbe; 2024 Aug; 32(8):1412-1426.e11. PubMed ID: 39094583
    [TBL] [Abstract][Full Text] [Related]  

  • 15. More Evidence of Collusion: a New Prophage-Mediated Viral Defense System Encoded by Mycobacteriophage Sbash.
    Gentile GM; Wetzel KS; Dedrick RM; Montgomery MT; Garlena RA; Jacobs-Sera D; Hatfull GF
    mBio; 2019 Mar; 10(2):. PubMed ID: 30890613
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure-guided discovery of anti-CRISPR and anti-phage defense proteins.
    Duan N; Hand E; Pheko M; Sharma S; Emiola A
    Nat Commun; 2024 Jan; 15(1):649. PubMed ID: 38245560
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unveil the Secret of the Bacteria and Phage Arms Race.
    Wang Y; Fan H; Tong Y
    Int J Mol Sci; 2023 Feb; 24(5):. PubMed ID: 36901793
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibiotics that affect translation can antagonize phage infectivity by interfering with the deployment of counter-defenses.
    Pons BJ; Dimitriu T; Westra ER; van Houte S
    Proc Natl Acad Sci U S A; 2023 Jan; 120(4):e2216084120. PubMed ID: 36669116
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phages, anti-CRISPR proteins, and drug-resistant bacteria: what do we know about this triad?
    Ceballos-Garzon A; Muñoz AB; Plata JD; Sanchez-Quitian ZA; Ramos-Vivas J
    Pathog Dis; 2022 Oct; 80(1):. PubMed ID: 36255384
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulated CRISPR Modules Exploit a Dual Defense Strategy of Restriction and Abortive Infection in a Model of Prokaryote-Phage Coevolution.
    Kumar MS; Plotkin JB; Hannenhalli S
    PLoS Comput Biol; 2015 Nov; 11(11):e1004603. PubMed ID: 26544847
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.